speb/financial-data huggingface dataset:
JBIO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 896000.00
JBIO income_statement (annual, 2025-12-31) — Interest Income: 7782000.00
JBIO income_statement (quarterly, 2025-12-31) — Interest Income: 3085000.00
JBIO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 7782000.00
JBIO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 3085000.00
JBIO balance_sheet (annual, 2025-12-31) — Invested Capital: 332516000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 332516000.00
JBIO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -247006000.00
JBIO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -98162000.00
JBIO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 189111000.00
JBIO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: -1341000.00
JBIO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
JBIO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
JBIO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 724000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 724000.00
JBIO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 724000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 724000.00
JBIO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
JBIO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
JBIO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 189111000.00
JBIO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -1341000.00
JBIO income_statement (annual, 2025-12-31) — Net Income: -127410000.00
JBIO income_statement (quarterly, 2025-12-31) — Net Income: -31932000.00
JBIO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -127410000.00
JBIO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -31932000.00
JBIO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -127410000.00
JBIO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -31932000.00
JBIO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -127410000.00
JBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -31932000.00
JBIO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -127410000.00
JBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -31932000.00
JBIO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -127410000.00
JBIO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -31932000.00
JBIO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -127410000.00
JBIO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -31932000.00
JBIO income_statement (annual, 2025-12-31) — Net Interest Income: 7782000.00
JBIO income_statement (quarterly, 2025-12-31) — Net Interest Income: 3085000.00
JBIO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -246779000.00
JBIO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -98187000.00
JBIO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
JBIO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
JBIO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
JBIO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
JBIO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 7782000.00
JBIO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 3085000.00
JBIO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 171273000.00
JBIO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 171117000.00
JBIO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -31000.00
JBIO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 28000.00
JBIO balance_sheet (annual, 2025-12-31) — Net PPE: 896000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Net PPE: 896000.00
JBIO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -196000.00
JBIO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -3000.00
JBIO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 332518000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 332518000.00
JBIO income_statement (annual, 2025-12-31) — Normalized EBITDA: -113516000.00
JBIO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -34970000.00
JBIO income_statement (annual, 2025-12-31) — Normalized Income: -127410000.00
JBIO income_statement (quarterly, 2025-12-31) — Normalized Income: -31932000.00
JBIO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -94689000.00
JBIO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -33649000.00
JBIO income_statement (annual, 2025-12-31) — Operating Income: -113542000.00
JBIO income_statement (quarterly, 2025-12-31) — Operating Income: -34979000.00
JBIO income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
JBIO income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
JBIO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 49316287.00
JBIO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 49316287.00
JBIO balance_sheet (annual, 2025-12-31) — Other Current Assets: 12658000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 12658000.00
JBIO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 129000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 129000.00
JBIO income_statement (annual, 2025-12-31) — Other Gand A: 7730000.00
JBIO income_statement (quarterly, 2025-12-31) — Other Gand A: 2008000.00
JBIO income_statement (annual, 2025-12-31) — Other Income Expense: -21592000.00
JBIO income_statement (quarterly, 2025-12-31) — Other Income Expense: 20000.00
JBIO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 21667000.00
JBIO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 26000.00
JBIO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 69000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 69000.00
JBIO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -21592000.00
JBIO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 20000.00
JBIO balance_sheet (annual, 2025-12-31) — Other Properties: 896000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Other Properties: 896000.00
JBIO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 247720000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 247720000.00
JBIO balance_sheet (annual, 2025-12-31) — Payables: 2151000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Payables: 2151000.00
JBIO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 13216000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 13216000.00
JBIO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3323000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3323000.00
JBIO balance_sheet (annual, 2025-12-31) — Preferred Securities Outside Stock Equity: 0.00
JBIO balance_sheet (quarterly, 2025-12-31) — Preferred Securities Outside Stock Equity: 0.00
JBIO balance_sheet (annual, 2025-12-31) — Preferred Stock: 2000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 2000.00
JBIO balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 2000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 2000.00
JBIO income_statement (annual, 2025-12-31) — Pretax Income: -127352000.00
JBIO income_statement (quarterly, 2025-12-31) — Pretax Income: -31874000.00
JBIO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 384000.00
JBIO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -261194000.00
JBIO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -112602000.00
JBIO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -196000.00
JBIO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -3000.00
JBIO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 26000.00
JBIO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 9000.00
JBIO income_statement (annual, 2025-12-31) — Research And Development: 93121000.00
JBIO income_statement (quarterly, 2025-12-31) — Research And Development: 28541000.00
JBIO balance_sheet (annual, 2025-12-31) — Retained Earnings: -174389000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -174389000.00
JBIO income_statement (annual, 2025-12-31) — Salaries And Wages: 12691000.00
JBIO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 4430000.00
JBIO cash_flow (annual, 2025-12-31) — Sale Of Investment: 14415000.00
JBIO income_statement (annual, 2025-12-31) — Selling General And Administration: 20421000.00
JBIO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 6438000.00
JBIO balance_sheet (annual, 2025-12-31) — Share Issued: 49316287.00
JBIO balance_sheet (quarterly, 2025-12-31) — Share Issued: 49316287.00
JBIO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 20009000.00
JBIO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 9396000.00
JBIO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 332518000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 332518000.00
JBIO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 332516000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 332516000.00
JBIO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
JBIO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
JBIO income_statement (annual, 2025-12-31) — Tax Provision: 58000.00
JBIO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
JBIO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
JBIO balance_sheet (annual, 2025-12-31) — Total Assets: 349781000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Total Assets: 349781000.00
JBIO balance_sheet (annual, 2025-12-31) — Total Capitalization: 332518000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 332518000.00
JBIO balance_sheet (annual, 2025-12-31) — Total Debt: 724000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Total Debt: 724000.00
JBIO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 332518000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 332518000.00
JBIO income_statement (annual, 2025-12-31) — Total Expenses: 113542000.00
JBIO income_statement (quarterly, 2025-12-31) — Total Expenses: 34979000.00
JBIO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 17263000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 17263000.00
JBIO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 965000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 965000.00
JBIO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 724000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 724000.00
JBIO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -113542000.00
JBIO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -34979000.00
JBIO balance_sheet (annual, 2025-12-31) — Working Capital: 332277000.00
JBIO balance_sheet (quarterly, 2025-12-31) — Working Capital: 332277000.00
JBIO income_statement (quarterly, 2026-03-31) — +Operating Expense: 43445000.00
JBIO income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
JBIO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3979000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 511554000.00
JBIO cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -493000.00
JBIO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 57777165.00
JBIO income_statement (quarterly, 2026-03-31) — Basic EPS: -0.57
JBIO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 88438000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 679000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 7000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 55085000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 311295000.00
JBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -795000.00
JBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -8470000.00
JBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -24081000.00
JBIO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 2328000.00
JBIO cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 1597000.00
JBIO cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 0.00
JBIO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -29000.00
JBIO cash_flow (quarterly, 2026-03-31) — Change In Payable: 2328000.00
JBIO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 3925000.00
JBIO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 5444000.00
JBIO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 9340000.00
JBIO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -33346000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Common Stock: 5000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 296460000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 12900000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Current Assets: 318517000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 22292000.00
JBIO cash_flow (quarterly, 2026-03-31) — Depreciation: 9000.00
JBIO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 9000.00
JBIO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 9000.00
JBIO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 57777165.00
JBIO income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.57
JBIO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -40368000.00
JBIO income_statement (quarterly, 2026-03-31) — EBIT: -43445000.00
JBIO income_statement (quarterly, 2026-03-31) — EBITDA: -43436000.00
JBIO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -7000.00
JBIO cash_flow (quarterly, 2026-03-31) — End Cash Position: 55085000.00
JBIO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -795000.00
JBIO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -24081000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -342000.00
JBIO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 7392000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 847000.00
JBIO income_statement (quarterly, 2026-03-31) — Interest Income: 3102000.00
JBIO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3102000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 296460000.00
JBIO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -8470000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 679000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 679000.00
JBIO income_statement (quarterly, 2026-03-31) — Net Income: -40368000.00
JBIO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -40368000.00
JBIO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -40368000.00
JBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -40368000.00
JBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -40368000.00
JBIO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -40368000.00
JBIO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -40368000.00
JBIO income_statement (quarterly, 2026-03-31) — Net Interest Income: 3102000.00
JBIO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -8470000.00
JBIO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 3102000.00
JBIO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -840000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Net PPE: 847000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 296462000.00
JBIO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -43436000.00
JBIO income_statement (quarterly, 2026-03-31) — Normalized Income: -40368000.00
JBIO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -24081000.00
JBIO income_statement (quarterly, 2026-03-31) — Operating Income: -43445000.00
JBIO income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
JBIO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 49345967.00
JBIO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 7222000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 2667000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -342000.00
JBIO income_statement (quarterly, 2026-03-31) — Other Gand A: 2094000.00
JBIO income_statement (quarterly, 2026-03-31) — Other Income Expense: -9000.00
JBIO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 26000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 69000.00
JBIO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -9000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Other Properties: 847000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 256210000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Payables: 3979000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 16879000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2746000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 2000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 2000.00
JBIO income_statement (quarterly, 2026-03-31) — Pretax Income: -40352000.00
JBIO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 45000.00
JBIO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -73898000.00
JBIO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 9000.00
JBIO income_statement (quarterly, 2026-03-31) — Research And Development: 36053000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -214757000.00
JBIO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 5298000.00
JBIO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 65428000.00
JBIO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 7392000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Share Issued: 49345967.00
JBIO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 7405000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 296462000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 296460000.00
JBIO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
JBIO income_statement (quarterly, 2026-03-31) — Tax Provision: 16000.00
JBIO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
JBIO balance_sheet (quarterly, 2026-03-31) — Total Assets: 319433000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 296462000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Total Debt: 679000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 296462000.00
JBIO income_statement (quarterly, 2026-03-31) — Total Expenses: 43445000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 22971000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 916000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 679000.00
JBIO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -43445000.00
JBIO balance_sheet (quarterly, 2026-03-31) — Working Capital: 296225000.00
JBL cash_flow (annual, 2021-08-31) — Common Stock Dividend Paid: -50000000.00
JBL cash_flow (annual, 2021-08-31) — Gain Loss On Investment Securities: -2000000.00
JBL cash_flow (annual, 2021-08-31) — Gain Loss On Sale Of PPE: 14000000.00
JBL income_statement (annual, 2021-08-31) — Gain On Sale Of Security: 2000000.00
JBL income_statement (annual, 2021-08-31) — Interest Income: 6000000.00
JBL income_statement (annual, 2021-08-31) — Interest Income Non Operating: 6000000.00
JBL cash_flow (annual, 2021-08-31) — Operating Gains Losses: 14000000.00
JBL cash_flow (annual, 2021-08-31) — Provisionand Write Offof Assets: 6000000.00
JBL income_statement (annual, 2022-08-31) — +Operating Expense: 1221000000.00
JBL income_statement (annual, 2022-08-31) — +Total Revenue: 33478000000.00
JBL balance_sheet (annual, 2022-08-31) — Accounts Payable: 8006000000.00
JBL balance_sheet (annual, 2022-08-31) — Accounts Receivable: 3995000000.00
JBL balance_sheet (annual, 2022-08-31) — Accumulated Depreciation: -5624000000.00
JBL balance_sheet (annual, 2022-08-31) — Additional Paid In Capital: 2655000000.00
JBL income_statement (annual, 2022-08-31) — Amortization: 34000000.00
JBL cash_flow (annual, 2022-08-31) — Amortization Cash Flow: 34000000.00
JBL cash_flow (annual, 2022-08-31) — Amortization Of Intangibles: 34000000.00
JBL income_statement (annual, 2022-08-31) — Amortization Of Intangibles Income Statement: 34000000.00
JBL balance_sheet (annual, 2022-08-31) — Assets Held For Sale Current: 0.00
JBL income_statement (annual, 2022-08-31) — Basic Average Shares: 141200000.00
JBL income_statement (annual, 2022-08-31) — Basic EPS: 7.06
JBL cash_flow (annual, 2022-08-31) — Beginning Cash Position: 1567000000.00
JBL balance_sheet (annual, 2022-08-31) — Buildings And Improvements: 1191000000.00
JBL cash_flow (annual, 2022-08-31) — Capital Expenditure: -1385000000.00
JBL balance_sheet (annual, 2022-08-31) — Capital Lease Obligations: 536000000.00
JBL balance_sheet (annual, 2022-08-31) — Capital Stock: 0.00
JBL balance_sheet (annual, 2022-08-31) — Cash And Cash Equivalents: 1478000000.00
JBL balance_sheet (annual, 2022-08-31) — Cash Cash Equivalents And Short Term Investments: 1478000000.00
JBL cash_flow (annual, 2022-08-31) — Cash Dividends Paid: -48000000.00
JBL cash_flow (annual, 2022-08-31) — Cash Flow From Continuing Financing Activities: -888000000.00
JBL cash_flow (annual, 2022-08-31) — Cash Flow From Continuing Investing Activities: -858000000.00
JBL cash_flow (annual, 2022-08-31) — Cash Flow From Continuing Operating Activities: 1651000000.00
JBL cash_flow (annual, 2022-08-31) — Change In Account Payable: 2866000000.00
JBL cash_flow (annual, 2022-08-31) — Change In Inventory: -1725000000.00
JBL cash_flow (annual, 2022-08-31) — Change In Other Current Assets: -29000000.00
JBL cash_flow (annual, 2022-08-31) — Change In Payable: 2866000000.00
JBL cash_flow (annual, 2022-08-31) — Change In Payables And Accrued Expense: 2866000000.00
JBL cash_flow (annual, 2022-08-31) — Change In Prepaid Assets: -367000000.00
JBL cash_flow (annual, 2022-08-31) — Change In Receivables: -1092000000.00
JBL cash_flow (annual, 2022-08-31) — Change In Working Capital: -347000000.00
JBL cash_flow (annual, 2022-08-31) — Changes In Account Receivables: -878000000.00
JBL cash_flow (annual, 2022-08-31) — Changes In Cash: -95000000.00
JBL balance_sheet (annual, 2022-08-31) — Common Stock: 0.00
JBL cash_flow (annual, 2022-08-31) — Common Stock Dividend Paid: -48000000.00
JBL balance_sheet (annual, 2022-08-31) — Common Stock Equity: 2451000000.00
JBL cash_flow (annual, 2022-08-31) — Common Stock Payments: -696000000.00
JBL balance_sheet (annual, 2022-08-31) — Construction In Progress: 179000000.00
JBL income_statement (annual, 2022-08-31) — Cost Of Revenue: 30846000000.00
JBL balance_sheet (annual, 2022-08-31) — Current Accrued Expenses: 3670000000.00
JBL balance_sheet (annual, 2022-08-31) — Current Assets: 13908000000.00
JBL balance_sheet (annual, 2022-08-31) — Current Capital Lease Obligation: 119000000.00
JBL balance_sheet (annual, 2022-08-31) — Current Debt: 300000000.00
JBL balance_sheet (annual, 2022-08-31) — Current Debt And Capital Lease Obligation: 419000000.00
JBL balance_sheet (annual, 2022-08-31) — Current Deferred Liabilities: 796000000.00
JBL balance_sheet (annual, 2022-08-31) — Current Deferred Revenue: 796000000.00
JBL balance_sheet (annual, 2022-08-31) — Current Liabilities: 13697000000.00
JBL cash_flow (annual, 2022-08-31) — Deferred Income Tax: -13000000.00
JBL cash_flow (annual, 2022-08-31) — Deferred Tax: -13000000.00
JBL cash_flow (annual, 2022-08-31) — Depreciation: 891000000.00
JBL cash_flow (annual, 2022-08-31) — Depreciation Amortization Depletion: 925000000.00
JBL income_statement (annual, 2022-08-31) — Depreciation Amortization Depletion Income Statement: 34000000.00
JBL cash_flow (annual, 2022-08-31) — Depreciation And Amortization: 925000000.00
JBL income_statement (annual, 2022-08-31) — Depreciation And Amortization In Income Statement: 34000000.00
JBL income_statement (annual, 2022-08-31) — Diluted Average Shares: 144400000.00
JBL income_statement (annual, 2022-08-31) — Diluted EPS: 6.90
JBL income_statement (annual, 2022-08-31) — Diluted NI Availto Com Stockholders: 996000000.00
JBL income_statement (annual, 2022-08-31) — EBIT: 1377000000.00
JBL income_statement (annual, 2022-08-31) — EBITDA: 2302000000.00
JBL cash_flow (annual, 2022-08-31) — Effect Of Exchange Rate Changes: 6000000.00
JBL cash_flow (annual, 2022-08-31) — End Cash Position: 1478000000.00
JBL cash_flow (annual, 2022-08-31) — Financing Cash Flow: -888000000.00
JBL balance_sheet (annual, 2022-08-31) — Finished Goods: 605000000.00
JBL cash_flow (annual, 2022-08-31) — Free Cash Flow: 266000000.00
JBL cash_flow (annual, 2022-08-31) — Gain Loss On Sale Of Business: 0.00
JBL cash_flow (annual, 2022-08-31) — Gain Loss On Sale Of PPE: 0.00
JBL income_statement (annual, 2022-08-31) — Gain On Sale Of Business: 0.00
JBL balance_sheet (annual, 2022-08-31) — Gains Losses Not Affecting Retained Earnings: -42000000.00
JBL balance_sheet (annual, 2022-08-31) — Goodwill: 704000000.00
JBL balance_sheet (annual, 2022-08-31) — Goodwill And Other Intangible Assets: 862000000.00
JBL balance_sheet (annual, 2022-08-31) — Gross PPE: 10078000000.00
JBL income_statement (annual, 2022-08-31) — Gross Profit: 2632000000.00
JBL cash_flow (annual, 2022-08-31) — Income Tax Paid Supplemental Data: 209000000.00
JBL income_statement (annual, 2022-08-31) — Interest Expense: 146000000.00
JBL income_statement (annual, 2022-08-31) — Interest Expense Non Operating: 146000000.00
JBL income_statement (annual, 2022-08-31) — Interest Income: 5000000.00
JBL income_statement (annual, 2022-08-31) — Interest Income Non Operating: 5000000.00
JBL cash_flow (annual, 2022-08-31) — Interest Paid Supplemental Data: 150000000.00
JBL balance_sheet (annual, 2022-08-31) — Inventories Adjustments Allowances: -82000000.00
JBL balance_sheet (annual, 2022-08-31) — Inventory: 6128000000.00
JBL balance_sheet (annual, 2022-08-31) — Invested Capital: 5326000000.00
JBL cash_flow (annual, 2022-08-31) — Investing Cash Flow: -858000000.00
JBL cash_flow (annual, 2022-08-31) — Issuance Of Debt: 3767000000.00
JBL balance_sheet (annual, 2022-08-31) — Land And Improvements: 108000000.00
JBL balance_sheet (annual, 2022-08-31) — Leases: 1362000000.00
JBL balance_sheet (annual, 2022-08-31) — Long Term Capital Lease Obligation: 417000000.00
JBL balance_sheet (annual, 2022-08-31) — Long Term Debt: 2575000000.00
JBL balance_sheet (annual, 2022-08-31) — Long Term Debt And Capital Lease Obligation: 2992000000.00
JBL cash_flow (annual, 2022-08-31) — Long Term Debt Issuance: 3767000000.00
JBL cash_flow (annual, 2022-08-31) — Long Term Debt Payments: -3890000000.00
JBL balance_sheet (annual, 2022-08-31) — Machinery Furniture Equipment: 6738000000.00
JBL balance_sheet (annual, 2022-08-31) — Minority Interest: 1000000.00
JBL income_statement (annual, 2022-08-31) — Minority Interests: 0.00
JBL cash_flow (annual, 2022-08-31) — Net Business Purchase And Sale: -18000000.00
JBL cash_flow (annual, 2022-08-31) — Net Common Stock Issuance: -696000000.00
JBL balance_sheet (annual, 2022-08-31) — Net Debt: 1397000000.00
JBL income_statement (annual, 2022-08-31) — Net Income: 996000000.00
JBL income_statement (annual, 2022-08-31) — Net Income Common Stockholders: 996000000.00
JBL income_statement (annual, 2022-08-31) — Net Income Continuous Operations: 996000000.00
JBL income_statement (annual, 2022-08-31) — Net Income From Continuing And Discontinued Operation: 996000000.00
JBL income_statement (annual, 2022-08-31) — Net Income From Continuing Operation Net Minority Interest: 996000000.00
JBL cash_flow (annual, 2022-08-31) — Net Income From Continuing Operations: 996000000.00
JBL income_statement (annual, 2022-08-31) — Net Income Including Noncontrolling Interests: 996000000.00
JBL income_statement (annual, 2022-08-31) — Net Interest Income: -146000000.00
JBL cash_flow (annual, 2022-08-31) — Net Issuance Payments Of Debt: -123000000.00
JBL cash_flow (annual, 2022-08-31) — Net Long Term Debt Issuance: -123000000.00
JBL income_statement (annual, 2022-08-31) — Net Non Operating Interest Income Expense: -146000000.00
JBL cash_flow (annual, 2022-08-31) — Net Other Financing Charges: -66000000.00
JBL cash_flow (annual, 2022-08-31) — Net Other Investing Changes: 1000000.00
JBL balance_sheet (annual, 2022-08-31) — Net PPE: 4454000000.00
JBL cash_flow (annual, 2022-08-31) — Net PPE Purchase And Sale: -841000000.00
JBL balance_sheet (annual, 2022-08-31) — Net Tangible Assets: 1589000000.00
JBL balance_sheet (annual, 2022-08-31) — Non Current Deferred Assets: 199000000.00
JBL balance_sheet (annual, 2022-08-31) — Non Current Deferred Liabilities: 122000000.00
JBL balance_sheet (annual, 2022-08-31) — Non Current Deferred Taxes Assets: 199000000.00
JBL balance_sheet (annual, 2022-08-31) — Non Current Deferred Taxes Liabilities: 122000000.00
JBL income_statement (annual, 2022-08-31) — Normalized EBITDA: 2324000000.00
JBL income_statement (annual, 2022-08-31) — Normalized Income: 1013798000.00
JBL cash_flow (annual, 2022-08-31) — Operating Cash Flow: 1651000000.00
JBL income_statement (annual, 2022-08-31) — Operating Income: 1411000000.00
JBL income_statement (annual, 2022-08-31) — Operating Revenue: 33478000000.00
JBL balance_sheet (annual, 2022-08-31) — Ordinary Shares Number: 135493980.00
JBL balance_sheet (annual, 2022-08-31) — Other Current Borrowings: 300000000.00
JBL balance_sheet (annual, 2022-08-31) — Other Equity Adjustments: -42000000.00
JBL income_statement (annual, 2022-08-31) — Other Income Expense: -34000000.00
JBL balance_sheet (annual, 2022-08-31) — Other Intangible Assets: 158000000.00
JBL cash_flow (annual, 2022-08-31) — Other Non Cash Items: 9000000.00
JBL balance_sheet (annual, 2022-08-31) — Other Non Current Assets: 294000000.00
JBL balance_sheet (annual, 2022-08-31) — Other Non Current Liabilities: 272000000.00
JBL income_statement (annual, 2022-08-31) — Other Non Operating Income Expenses: -12000000.00
JBL balance_sheet (annual, 2022-08-31) — Other Properties: 500000000.00
JBL balance_sheet (annual, 2022-08-31) — Other Receivables: 1196000000.00
JBL income_statement (annual, 2022-08-31) — Other Special Charges: 4000000.00
JBL balance_sheet (annual, 2022-08-31) — Payables: 8006000000.00
JBL balance_sheet (annual, 2022-08-31) — Payables And Accrued Expenses: 11676000000.00
JBL balance_sheet (annual, 2022-08-31) — Pensionand Other Post Retirement Benefit Plans Current: 806000000.00
JBL balance_sheet (annual, 2022-08-31) — Preferred Stock: 0.00
JBL balance_sheet (annual, 2022-08-31) — Prepaid Assets: 1111000000.00
JBL income_statement (annual, 2022-08-31) — Pretax Income: 1231000000.00
JBL cash_flow (annual, 2022-08-31) — Proceeds From Stock Option Exercised: 45000000.00
JBL balance_sheet (annual, 2022-08-31) — Properties: 0.00
JBL cash_flow (annual, 2022-08-31) — Provisionand Write Offof Assets: 0.00
JBL cash_flow (annual, 2022-08-31) — Purchase Of Business: -18000000.00
JBL cash_flow (annual, 2022-08-31) — Purchase Of PPE: -1385000000.00
JBL balance_sheet (annual, 2022-08-31) — Raw Materials: 4918000000.00
JBL balance_sheet (annual, 2022-08-31) — Receivables: 5191000000.00
JBL income_statement (annual, 2022-08-31) — Reconciled Cost Of Revenue: 29955000000.00
JBL income_statement (annual, 2022-08-31) — Reconciled Depreciation: 925000000.00
JBL cash_flow (annual, 2022-08-31) — Repayment Of Debt: -3890000000.00
JBL cash_flow (annual, 2022-08-31) — Repurchase Of Capital Stock: -696000000.00
JBL income_statement (annual, 2022-08-31) — Research And Development: 33000000.00
JBL income_statement (annual, 2022-08-31) — Restructuring And Mergern Acquisition: 18000000.00
JBL balance_sheet (annual, 2022-08-31) — Retained Earnings: 3638000000.00
JBL cash_flow (annual, 2022-08-31) — Sale Of Business: 0.00
JBL cash_flow (annual, 2022-08-31) — Sale Of PPE: 544000000.00
JBL income_statement (annual, 2022-08-31) — Selling General And Administration: 1154000000.00
JBL balance_sheet (annual, 2022-08-31) — Share Issued: 270891715.00
JBL income_statement (annual, 2022-08-31) — Special Income Charges: -22000000.00
JBL cash_flow (annual, 2022-08-31) — Stock Based Compensation: 81000000.00
JBL balance_sheet (annual, 2022-08-31) — Stockholders Equity: 2451000000.00
JBL balance_sheet (annual, 2022-08-31) — Tangible Book Value: 1589000000.00
JBL income_statement (annual, 2022-08-31) — Tax Effect Of Unusual Items: -4202000.00
JBL income_statement (annual, 2022-08-31) — Tax Provision: 235000000.00
JBL income_statement (annual, 2022-08-31) — Tax Rate For Calcs: 0.19
JBL balance_sheet (annual, 2022-08-31) — Total Assets: 19717000000.00
JBL balance_sheet (annual, 2022-08-31) — Total Capitalization: 5026000000.00
JBL balance_sheet (annual, 2022-08-31) — Total Debt: 3411000000.00
JBL balance_sheet (annual, 2022-08-31) — Total Equity Gross Minority Interest: 2452000000.00
JBL income_statement (annual, 2022-08-31) — Total Expenses: 32067000000.00
JBL balance_sheet (annual, 2022-08-31) — Total Liabilities Net Minority Interest: 17265000000.00
JBL balance_sheet (annual, 2022-08-31) — Total Non Current Assets: 5809000000.00
JBL balance_sheet (annual, 2022-08-31) — Total Non Current Liabilities Net Minority Interest: 3568000000.00
JBL income_statement (annual, 2022-08-31) — Total Operating Income As Reported: 1393000000.00
JBL income_statement (annual, 2022-08-31) — Total Unusual Items: -22000000.00
JBL income_statement (annual, 2022-08-31) — Total Unusual Items Excluding Goodwill: -22000000.00
JBL balance_sheet (annual, 2022-08-31) — Tradeand Other Payables Non Current: 182000000.00
JBL balance_sheet (annual, 2022-08-31) — Treasury Shares Number: 135397735.00
JBL balance_sheet (annual, 2022-08-31) — Treasury Stock: 3800000000.00
JBL balance_sheet (annual, 2022-08-31) — Work In Process: 687000000.00
JBL balance_sheet (annual, 2022-08-31) — Working Capital: 211000000.00
JBL income_statement (annual, 2022-08-31) — Write Off: 0.00
JBL income_statement (annual, 2023-08-31) — +Operating Expense: 1273000000.00
JBL income_statement (annual, 2023-08-31) — +Total Revenue: 34702000000.00
JBL balance_sheet (annual, 2023-08-31) — Accounts Payable: 5679000000.00
JBL balance_sheet (annual, 2023-08-31) — Accounts Receivable: 3647000000.00
JBL balance_sheet (annual, 2023-08-31) — Accumulated Depreciation: -4512000000.00
JBL balance_sheet (annual, 2023-08-31) — Additional Paid In Capital: 2795000000.00
JBL income_statement (annual, 2023-08-31) — Amortization: 33000000.00
JBL cash_flow (annual, 2023-08-31) — Amortization Cash Flow: 33000000.00
JBL cash_flow (annual, 2023-08-31) — Amortization Of Intangibles: 33000000.00
JBL income_statement (annual, 2023-08-31) — Amortization Of Intangibles Income Statement: 33000000.00
JBL balance_sheet (annual, 2023-08-31) — Assets Held For Sale Current: 1929000000.00
JBL income_statement (annual, 2023-08-31) — Basic Average Shares: 133000000.00
JBL income_statement (annual, 2023-08-31) — Basic EPS: 6.15
JBL cash_flow (annual, 2023-08-31) — Beginning Cash Position: 1478000000.00
JBL balance_sheet (annual, 2023-08-31) — Buildings And Improvements: 1281000000.00
JBL cash_flow (annual, 2023-08-31) — Capital Expenditure: -1030000000.00
JBL balance_sheet (annual, 2023-08-31) — Capital Lease Obligations: 373000000.00
JBL balance_sheet (annual, 2023-08-31) — Capital Stock: 0.00
JBL balance_sheet (annual, 2023-08-31) — Cash And Cash Equivalents: 1804000000.00
JBL balance_sheet (annual, 2023-08-31) — Cash Cash Equivalents And Short Term Investments: 1804000000.00
JBL cash_flow (annual, 2023-08-31) — Cash Dividends Paid: -45000000.00
JBL cash_flow (annual, 2023-08-31) — Cash Flow From Continuing Financing Activities: -680000000.00
JBL cash_flow (annual, 2023-08-31) — Cash Flow From Continuing Investing Activities: -723000000.00
JBL cash_flow (annual, 2023-08-31) — Cash Flow From Continuing Operating Activities: 1734000000.00
JBL cash_flow (annual, 2023-08-31) — Change In Account Payable: -853000000.00
JBL cash_flow (annual, 2023-08-31) — Change In Inventory: 370000000.00
JBL cash_flow (annual, 2023-08-31) — Change In Other Current Assets: 53000000.00
JBL cash_flow (annual, 2023-08-31) — Change In Payable: -853000000.00
JBL cash_flow (annual, 2023-08-31) — Change In Payables And Accrued Expense: -853000000.00
JBL cash_flow (annual, 2023-08-31) — Change In Prepaid Assets: -214000000.00
JBL cash_flow (annual, 2023-08-31) — Change In Receivables: 438000000.00
JBL cash_flow (annual, 2023-08-31) — Change In Working Capital: -206000000.00
JBL cash_flow (annual, 2023-08-31) — Changes In Account Receivables: 267000000.00
JBL cash_flow (annual, 2023-08-31) — Changes In Cash: 331000000.00
JBL balance_sheet (annual, 2023-08-31) — Common Stock: 0.00
JBL balance_sheet (annual, 2023-08-31) — Common Stock Equity: 2866000000.00
JBL cash_flow (annual, 2023-08-31) — Common Stock Payments: -487000000.00
JBL balance_sheet (annual, 2023-08-31) — Construction In Progress: 147000000.00
JBL income_statement (annual, 2023-08-31) — Cost Of Revenue: 31835000000.00
JBL balance_sheet (annual, 2023-08-31) — Current Accrued Expenses: 3886000000.00
JBL balance_sheet (annual, 2023-08-31) — Current Assets: 14730000000.00
JBL balance_sheet (annual, 2023-08-31) — Current Capital Lease Obligation: 104000000.00
JBL balance_sheet (annual, 2023-08-31) — Current Debt And Capital Lease Obligation: 104000000.00
JBL balance_sheet (annual, 2023-08-31) — Current Deferred Liabilities: 886000000.00
JBL balance_sheet (annual, 2023-08-31) — Current Deferred Revenue: 886000000.00
JBL balance_sheet (annual, 2023-08-31) — Current Liabilities: 12695000000.00
JBL cash_flow (annual, 2023-08-31) — Deferred Income Tax: 85000000.00
JBL cash_flow (annual, 2023-08-31) — Deferred Tax: 85000000.00
JBL cash_flow (annual, 2023-08-31) — Depreciation: 891000000.00
JBL cash_flow (annual, 2023-08-31) — Depreciation Amortization Depletion: 924000000.00
JBL income_statement (annual, 2023-08-31) — Depreciation Amortization Depletion Income Statement: 33000000.00
JBL cash_flow (annual, 2023-08-31) — Depreciation And Amortization: 924000000.00
JBL income_statement (annual, 2023-08-31) — Depreciation And Amortization In Income Statement: 33000000.00
JBL income_statement (annual, 2023-08-31) — Diluted Average Shares: 135900000.00
JBL income_statement (annual, 2023-08-31) — Diluted EPS: 6.02
JBL income_statement (annual, 2023-08-31) — Diluted NI Availto Com Stockholders: 818000000.00
JBL income_statement (annual, 2023-08-31) — EBIT: 1468000000.00
JBL income_statement (annual, 2023-08-31) — EBITDA: 2392000000.00
JBL cash_flow (annual, 2023-08-31) — Effect Of Exchange Rate Changes: -5000000.00
JBL cash_flow (annual, 2023-08-31) — End Cash Position: 1804000000.00
JBL cash_flow (annual, 2023-08-31) — Financing Cash Flow: -680000000.00
JBL balance_sheet (annual, 2023-08-31) — Finished Goods: 243000000.00
JBL cash_flow (annual, 2023-08-31) — Free Cash Flow: 704000000.00
JBL cash_flow (annual, 2023-08-31) — Gain Loss On Sale Of Business: 0.00
JBL cash_flow (annual, 2023-08-31) — Gain Loss On Sale Of PPE: 0.00
JBL income_statement (annual, 2023-08-31) — Gain On Sale Of Business: 0.00
JBL balance_sheet (annual, 2023-08-31) — Gains Losses Not Affecting Retained Earnings: -17000000.00
JBL balance_sheet (annual, 2023-08-31) — Goodwill: 621000000.00
JBL balance_sheet (annual, 2023-08-31) — Goodwill And Other Intangible Assets: 763000000.00
JBL balance_sheet (annual, 2023-08-31) — Gross PPE: 8016000000.00
JBL income_statement (annual, 2023-08-31) — Gross Profit: 2867000000.00
JBL cash_flow (annual, 2023-08-31) — Income Tax Paid Supplemental Data: 319000000.00
JBL income_statement (annual, 2023-08-31) — Interest Expense: 206000000.00
JBL income_statement (annual, 2023-08-31) — Interest Expense Non Operating: 206000000.00
JBL cash_flow (annual, 2023-08-31) — Interest Paid Supplemental Data: 211000000.00
JBL balance_sheet (annual, 2023-08-31) — Inventories Adjustments Allowances: -58000000.00
JBL balance_sheet (annual, 2023-08-31) — Inventory: 5206000000.00
JBL balance_sheet (annual, 2023-08-31) — Invested Capital: 5741000000.00
JBL cash_flow (annual, 2023-08-31) — Investing Cash Flow: -723000000.00
JBL cash_flow (annual, 2023-08-31) — Issuance Of Debt: 4047000000.00
JBL balance_sheet (annual, 2023-08-31) — Land And Improvements: 107000000.00
JBL balance_sheet (annual, 2023-08-31) — Leases: 676000000.00
JBL balance_sheet (annual, 2023-08-31) — Long Term Capital Lease Obligation: 269000000.00
JBL balance_sheet (annual, 2023-08-31) — Long Term Debt: 2875000000.00
JBL balance_sheet (annual, 2023-08-31) — Long Term Debt And Capital Lease Obligation: 3144000000.00
JBL cash_flow (annual, 2023-08-31) — Long Term Debt Issuance: 4047000000.00
JBL cash_flow (annual, 2023-08-31) — Long Term Debt Payments: -4204000000.00
JBL balance_sheet (annual, 2023-08-31) — Machinery Furniture Equipment: 5438000000.00
JBL balance_sheet (annual, 2023-08-31) — Minority Interest: 1000000.00
JBL income_statement (annual, 2023-08-31) — Minority Interests: 0.00
JBL cash_flow (annual, 2023-08-31) — Net Business Purchase And Sale: 21000000.00
JBL cash_flow (annual, 2023-08-31) — Net Common Stock Issuance: -487000000.00
JBL balance_sheet (annual, 2023-08-31) — Net Debt: 1071000000.00
JBL income_statement (annual, 2023-08-31) — Net Income: 818000000.00
JBL income_statement (annual, 2023-08-31) — Net Income Common Stockholders: 818000000.00
JBL income_statement (annual, 2023-08-31) — Net Income Continuous Operations: 818000000.00
JBL income_statement (annual, 2023-08-31) — Net Income From Continuing And Discontinued Operation: 818000000.00
JBL income_statement (annual, 2023-08-31) — Net Income From Continuing Operation Net Minority Interest: 818000000.00
JBL cash_flow (annual, 2023-08-31) — Net Income From Continuing Operations: 818000000.00
JBL income_statement (annual, 2023-08-31) — Net Income Including Noncontrolling Interests: 818000000.00
JBL income_statement (annual, 2023-08-31) — Net Interest Income: -206000000.00
JBL cash_flow (annual, 2023-08-31) — Net Issuance Payments Of Debt: -157000000.00
JBL cash_flow (annual, 2023-08-31) — Net Long Term Debt Issuance: -157000000.00
JBL income_statement (annual, 2023-08-31) — Net Non Operating Interest Income Expense: -206000000.00
JBL cash_flow (annual, 2023-08-31) — Net Other Financing Charges: -42000000.00
JBL cash_flow (annual, 2023-08-31) — Net Other Investing Changes: -36000000.00
JBL balance_sheet (annual, 2023-08-31) — Net PPE: 3504000000.00
JBL cash_flow (annual, 2023-08-31) — Net PPE Purchase And Sale: -708000000.00
JBL balance_sheet (annual, 2023-08-31) — Net Tangible Assets: 2103000000.00
JBL balance_sheet (annual, 2023-08-31) — Non Current Deferred Assets: 159000000.00
JBL balance_sheet (annual, 2023-08-31) — Non Current Deferred Liabilities: 268000000.00
JBL balance_sheet (annual, 2023-08-31) — Non Current Deferred Taxes Assets: 159000000.00
JBL balance_sheet (annual, 2023-08-31) — Non Current Deferred Taxes Liabilities: 268000000.00
JBL income_statement (annual, 2023-08-31) — Normalized EBITDA: 2449000000.00
JBL income_statement (annual, 2023-08-31) — Normalized Income: 854936000.00
JBL cash_flow (annual, 2023-08-31) — Operating Cash Flow: 1734000000.00
JBL income_statement (annual, 2023-08-31) — Operating Income: 1594000000.00
JBL income_statement (annual, 2023-08-31) — Operating Revenue: 34702000000.00
JBL balance_sheet (annual, 2023-08-31) — Ordinary Shares Number: 131294422.00
JBL balance_sheet (annual, 2023-08-31) — Other Current Liabilities: 1397000000.00
JBL balance_sheet (annual, 2023-08-31) — Other Equity Adjustments: -17000000.00
JBL income_statement (annual, 2023-08-31) — Other Income Expense: -126000000.00
JBL balance_sheet (annual, 2023-08-31) — Other Intangible Assets: 142000000.00
JBL cash_flow (annual, 2023-08-31) — Other Non Cash Items: 18000000.00
JBL balance_sheet (annual, 2023-08-31) — Other Non Current Assets: 268000000.00
JBL balance_sheet (annual, 2023-08-31) — Other Non Current Liabilities: 319000000.00
JBL income_statement (annual, 2023-08-31) — Other Non Operating Income Expenses: -69000000.00
JBL balance_sheet (annual, 2023-08-31) — Other Properties: 367000000.00
JBL balance_sheet (annual, 2023-08-31) — Other Receivables: 1035000000.00
JBL balance_sheet (annual, 2023-08-31) — Payables: 5679000000.00
JBL balance_sheet (annual, 2023-08-31) — Payables And Accrued Expenses: 9565000000.00
JBL balance_sheet (annual, 2023-08-31) — Pensionand Other Post Retirement Benefit Plans Current: 743000000.00
JBL balance_sheet (annual, 2023-08-31) — Preferred Stock: 0.00
JBL balance_sheet (annual, 2023-08-31) — Prepaid Assets: 1109000000.00
JBL income_statement (annual, 2023-08-31) — Pretax Income: 1262000000.00
JBL cash_flow (annual, 2023-08-31) — Proceeds From Stock Option Exercised: 51000000.00
JBL balance_sheet (annual, 2023-08-31) — Properties: 0.00
JBL cash_flow (annual, 2023-08-31) — Purchase Of Business: -29000000.00
JBL cash_flow (annual, 2023-08-31) — Purchase Of PPE: -1030000000.00
JBL balance_sheet (annual, 2023-08-31) — Raw Materials: 4804000000.00
JBL balance_sheet (annual, 2023-08-31) — Receivables: 4682000000.00
JBL income_statement (annual, 2023-08-31) — Reconciled Cost Of Revenue: 30944000000.00
JBL income_statement (annual, 2023-08-31) — Reconciled Depreciation: 924000000.00
JBL cash_flow (annual, 2023-08-31) — Repayment Of Debt: -4204000000.00
JBL cash_flow (annual, 2023-08-31) — Repurchase Of Capital Stock: -487000000.00
JBL income_statement (annual, 2023-08-31) — Research And Development: 34000000.00
JBL income_statement (annual, 2023-08-31) — Restructuring And Mergern Acquisition: 52000000.00
JBL balance_sheet (annual, 2023-08-31) — Retained Earnings: 4412000000.00
JBL cash_flow (annual, 2023-08-31) — Sale Of Business: 50000000.00
JBL cash_flow (annual, 2023-08-31) — Sale Of PPE: 322000000.00
JBL income_statement (annual, 2023-08-31) — Selling General And Administration: 1206000000.00
JBL balance_sheet (annual, 2023-08-31) — Share Issued: 273949811.00
JBL income_statement (annual, 2023-08-31) — Special Income Charges: -57000000.00
JBL cash_flow (annual, 2023-08-31) — Stock Based Compensation: 95000000.00
JBL balance_sheet (annual, 2023-08-31) — Stockholders Equity: 2866000000.00
JBL balance_sheet (annual, 2023-08-31) — Tangible Book Value: 2103000000.00
JBL income_statement (annual, 2023-08-31) — Tax Effect Of Unusual Items: -20064000.00
JBL income_statement (annual, 2023-08-31) — Tax Provision: 444000000.00
JBL income_statement (annual, 2023-08-31) — Tax Rate For Calcs: 0.35
JBL balance_sheet (annual, 2023-08-31) — Total Assets: 19424000000.00
JBL balance_sheet (annual, 2023-08-31) — Total Capitalization: 5741000000.00
JBL balance_sheet (annual, 2023-08-31) — Total Debt: 3248000000.00
JBL balance_sheet (annual, 2023-08-31) — Total Equity Gross Minority Interest: 2867000000.00
JBL income_statement (annual, 2023-08-31) — Total Expenses: 33108000000.00